FULVICIN PG TAB 330MG 330 MG
GRISEOFULVIN : 330 MG · DIN 00513237 · SCHERING-PLOUGH CANADA INC
Health Canada status: CANCELLED POST MARKET
What is FULVICIN PG TAB 330MG?
FULVICIN PG TAB 330MG 330 MG contains GRISEOFULVIN : 330 MG. It is listed in the Health Canada Drug Product Database under DIN 00513237, held by SCHERING-PLOUGH CANADA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 17-Nov-1998. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00513237 |
|---|---|
| Brand name | FULVICIN PG TAB 330MG |
| Generic / active ingredient | GRISEOFULVIN : 330 MG |
| Manufacturer | SCHERING-PLOUGH CANADA INC |
| Strength | 330 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | D01BA01 GRISEOFULVIN |
| AHFS class | 08:14.92 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 17-Nov-1998 |
| Original market date | 1982-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code D01BA01 GRISEOFULVIN. 0 of 8 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| FULVICIN U/F TAB 250MG | 250 MG | TABLET | SCHERING-PLOUGH CANADA INC | CANCELLED POST MARKET | DIN 00028274 |
| FULVICIN UF TAB 500MG | 500 MG | TABLET | SCHERING-PLOUGH CANADA INC | CANCELLED POST MARKET | DIN 00028282 |
| GRISOVIN FP TAB 125MG | 125 MG | TABLET | GLAXO CANADA INC | CANCELLED POST MARKET | DIN 00012246 |
| GRISOVIN FP TAB 250MG | 250 MG | TABLET | GLAXO CANADA INC | CANCELLED POST MARKET | DIN 00012254 |
| GRISOVIN FP TAB 500MG | 500 MG | TABLET | GLAXO CANADA INC | CANCELLED POST MARKET | DIN 00012262 |
| GRISOVIN-FP 125MG TAB | 125 MG | TABLET | ROBERTS PHARMACEUTICAL CANADA INC. | CANCELLED POST MARKET | DIN 02100266 |
| GRISOVIN-FP 250MG TAB | 250 MG | TABLET | ROBERTS PHARMACEUTICAL CANADA INC. | CANCELLED POST MARKET | DIN 02100274 |
Who else supplies GRISEOFULVIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. GRISEOFULVIN appears in 13 registered pack listings across 4 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.